Semaglutide for PCOS: How GLP-1s Are Changing Treatment

Polycystic ovary syndrome affects an estimated 8-13% of women of reproductive age, making it one of the most common endocrine disorders. The conventional treatment approach, metformin, birth control pills, lifestyle changes, helps some women but leaves many still struggling with weight gain, irregular cycles, infertility, and androgen excess.

GLP-1 medications are changing this. Because PCOS is fundamentally driven by insulin resistance, and GLP-1s directly improve insulin sensitivity while driving weight loss, they're proving to be one of the most effective PCOS interventions available.

Why PCOS and GLP-1s work together

PCOS core mechanism:

1. Insulin resistance → elevated insulin
2. Elevated insulin → elevated ovarian androgens (testosterone, DHEA)
3. Elevated androgens → irregular cycles, acne, hair loss, hirsutism, weight gain, fertility problems
4. Insulin resistance also drives central obesity and metabolic dysfunction

GLP-1 mechanism:

1. Improves insulin sensitivity dramatically
2. Drives significant weight loss (especially visceral fat)
3. Reduces inflammation
4. Lowers fasting insulin

By targeting the root cause of PCOS, insulin resistance, GLP-1s unwind the entire downstream cascade.

Clinical evidence

A growing body of research on semaglutide in PCOS shows:

• 10-15% body weight loss over 6-12 months (often greater than in non-PCOS patients)
• Significant drop in fasting insulin
• Reduction in free testosterone in many patients
• Restored menstrual regularity in some women
• Improved ovulation and potential fertility benefits
• Reduced hirsutism and acne over time
• Lower hs-CRP and inflammatory markers

What to expect on semaglutide for PCOS

Months 1-3

• Appetite suppression begins
• Cravings (especially carb cravings) reduce
• Fasting insulin starts dropping
• Initial 8-12 lbs weight loss typical

Months 3-6

• Significant weight loss (typically 10-15% of body weight)
• Menstrual cycles may begin regulating
• Acne often improves
• Energy and mood lift
• Hair shedding sometimes reduces (long-term benefit)

Months 6-12

• Body composition dramatically improved
• Metabolic markers (insulin, A1C, lipids) often normalized
• Fertility may improve for women trying to conceive
• Androgen excess symptoms (hirsutism, acne) continue improving

GLP-1 vs. metformin for PCOS

Metformin has been the default PCOS medication for 20+ years. Research comparing the two shows GLP-1s producing meaningfully better outcomes across most endpoints:

• Weight loss: GLP-1s produce 3-5x more
• Insulin sensitivity: Both improve it; GLP-1s typically more
• Androgen reduction: GLP-1s often better
• Menstrual regulation: Similar to slightly better with GLP-1s
• Side effects: Metformin cheaper but more GI upset long-term

Many providers now use both together, metformin + semaglutide, for synergistic effects.

Fertility considerations

Many women with PCOS take semaglutide specifically to improve fertility. Important notes:

• Weight loss + improved insulin sensitivity both support ovulation
• However, semaglutide itself is not pregnancy-safe. Must be stopped at least 2 months before conception.
• Tirzepatide has a similar washout requirement
• Strategy: achieve weight loss on GLP-1 → stop 2+ months before trying → conceive
• Some women may need to restart postpartum if metabolic issues return

Tirzepatide for PCOS

Similar benefits to semaglutide but with greater weight loss (20%+ at max dose). For women with significant weight to lose alongside PCOS, tirzepatide is often the superior choice. See our.

Protocol considerations for PCOS

• Start with standard titration, PCOS doesn't change the dosing schedule
• Monitor androgens at 3 and 6 months, often drop meaningfully
• Monitor insulin, A1C, lipids
• Layer in strength training, insulin sensitivity gains compound with muscle
• High protein intake critical, PCOS-associated visceral fat loss without muscle loss requires it
• Inositol (myo + D-chiro, 40:1 ratio) pairs well with GLP-1s for PCOS
• Sleep and stress amplify everything, insulin resistance is particularly sensitive to both

Who is the best candidate?

• Women with PCOS + BMI > 25
• Women with PCOS + clear insulin resistance markers
• Women with PCOS who haven't responded adequately to metformin
• Women with PCOS planning pregnancy (with proper timing)
• Women with PCOS + prediabetes or type 2 diabetes

The bottom line

PCOS is primarily an insulin resistance problem, and GLP-1 medications are primarily insulin sensitizers that also drive dramatic weight loss. The fit is ideal. Women with PCOS often report that semaglutide or tirzepatide produces the first meaningful improvement in symptoms they've experienced after years of treatment. Paired with inositol, strength training, high protein, and proper sleep, the combination can be genuinely transformative.